We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Stryker Corporation (SYK) is a leading medical devices business with stocks listed in the US. It opened the day at US$264.11 after a previous close of US$263.89. During the day the price has varied from a low of USD262.26 to a high of USD265.95. The latest price was USD264.17 (25 minute delay). Stryker Corporation is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in Stryker Corporation
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Stryker Corporation. Find the share by name or ticker symbol: SYK. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Stryker Corporation reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Stryker Corporation, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Stryker Corporation. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Stryker Corporation key stats
- Compare share trading platforms
- Is Stryker Corporation stock a buy or sell?
- Stryker Corporation performance over time
- Can I short Stryker Corporation shares?
- Is Stryker Corporation suitable for ethical investing?
- Are Stryker Corporation shares over-valued?
- Stryker Corporation's financials
- How volatile are Stryker Corporation shares?
- Does Stryker Corporation pay a dividend?
- Have Stryker Corporation shares ever split?
- Other common questions
Stryker Corporation share priceUse our graph to track the performance of SYK stocks over time.
Stryker Corporation shares at a glance
|52-week range||US$169.817 - US$257.13|
|50-day moving average||US$242.0946|
|200-day moving average||US$233.693|
|Dividend yield||US$2.355 (0.93%)|
|Earnings per share (TTM)||US$4.2|
Compare share trading platforms to buy stock
Is it a good time to buy Stryker Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Stryker Corporation price performance over time
|1 month (2021-03-23)||15.14%|
Is Stryker Corporation under- or over-valued?
Valuing Stryker Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stryker Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Stryker Corporation's P/E ratio
Stryker Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, Stryker Corporation shares trade at around 61x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Stryker Corporation's PEG ratio
Stryker Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0575. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Stryker Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Stryker Corporation's EBITDA
Stryker Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$3.8 billion (£2.7 billion).
The EBITDA is a measure of a Stryker Corporation's overall financial performance and is widely used to measure a its profitability.
Stryker Corporation financials
|Revenue TTM||US$14.4 billion|
|Operating margin TTM||20.51%|
|Gross profit TTM||US$9.2 billion|
|Return on assets TTM||5.7%|
|Return on equity TTM||12.35%|
|Market capitalisation||US$96.7 billion|
TTM: trailing 12 months
Shorting Stryker Corporation shares
There are currently 3.6 million Stryker Corporation shares held short by investors – that's known as Stryker Corporation's "short interest". This figure is 13.9% up from 3.2 million last month.
There are a few different ways that this level of interest in shorting Stryker Corporation shares can be evaluated.
Stryker Corporation's "short interest ratio" (SIR)
Stryker Corporation's "short interest ratio" (SIR) is the quantity of Stryker Corporation shares currently shorted divided by the average quantity of Stryker Corporation shares traded daily (recently around 1.2 million). Stryker Corporation's SIR currently stands at 3. In other words for every 100,000 Stryker Corporation shares traded daily on the market, roughly 3000 shares are currently held short.
However Stryker Corporation's short interest can also be evaluated against the total number of Stryker Corporation shares, or, against the total number of tradable Stryker Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Stryker Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Stryker Corporation shares in existence, roughly 10 shares are currently held short) or 0.0104% of the tradable shares (for every 100,000 tradable Stryker Corporation shares, roughly 10 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Stryker Corporation.
Find out more about how you can short Stryker Corporation stock.
Stryker Corporation's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Stryker Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Stryker Corporation's total ESG risk score
Total ESG risk: 33.93
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Stryker Corporation's overall score of 33.93 (as at 12/31/2018) is pretty weak – landing it in it in the 71st percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Stryker Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Stryker Corporation's environmental score
Environmental score: 3.06/100
Stryker Corporation's environmental score of 3.06 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Stryker Corporation's social score
Social score: 14.68/100
Stryker Corporation's social score of 14.68 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Stryker Corporation's governance score
Governance score: 8.19/100
Stryker Corporation's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Stryker Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Stryker Corporation's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Stryker Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Stryker Corporation hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||33.93|
|Total ESG percentile||70.66|
|Environmental score percentile||1|
|Social score percentile||1|
|Governance score percentile||1|
|Level of controversy||3|
Stryker Corporation share dividends
Dividend payout ratio: 32.44% of net profits
Recently Stryker Corporation has paid out, on average, around 32.44% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.98% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Stryker Corporation shareholders could enjoy a 0.98% return on their shares, in the form of dividend payments. In Stryker Corporation's case, that would currently equate to about $2.355 per share.
While Stryker Corporation's payout ratio might seem fairly standard, it's worth remembering that Stryker Corporation may be investing much of the rest of its net profits in future growth.
Stryker Corporation's most recent dividend payout was on 29 April 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 March 2021 (the "ex-dividend date").
Have Stryker Corporation's shares ever split?
Stryker Corporation's shares were split on a 2:1 basis on 16 May 2004. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Stryker Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Stryker Corporation shares which in turn could have impacted Stryker Corporation's share price.
Stryker Corporation share price volatility
Over the last 12 months, Stryker Corporation's shares have ranged in value from as little as US$169.817 up to US$257.13. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Stryker Corporation's is 0.9542. This would suggest that Stryker Corporation's shares are less volatile than average (for this exchange).
Stryker Corporation overview
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Frequently asked questions
Ask an Expert